Literature DB >> 3054810

A mutation in the 530 loop of Escherichia coli 16S ribosomal RNA causes resistance to streptomycin.

P Melançon1, C Lemieux, L Brakier-Gingras.   

Abstract

Oligonucleotide-directed mutagenesis was used to introduce an A to C transversion at position 523 in the 16S ribosomal RNA gene of Escherichia coli rrnB operon cloned in plasmid pKK3535. E. coli cells transformed with the mutated plasmid were resistant to streptomycin. The mutated ribosomes isolated from these cells were not stimulated by streptomycin to misread the message in a poly(U)-directed assay. They were also restrictive to the stimulation of misreading by other error-promoting related aminoglycoside antibiotics such as neomycin, kanamycin or gentamicin, which do not compete for the streptomycin binding site. The 530 loop where the mutation in the 16S rRNA is located has been mapped at the external surface of the 30S subunit, and is therefore distal from the streptomycin binding site at the subunit interface. Our results support the conclusion that the mutation at position 523 in the 16S rRNA does not interfere with the binding of streptomycin, but prevents the drug from inducing conformational changes in the 530 loop which account for its miscoding effect. Since this effect primarily results from a perturbation of the translational proofreading control, our results also provide evidence that the 530 loop of the 16S rRNA is involved in this accuracy control.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3054810      PMCID: PMC338768          DOI: 10.1093/nar/16.20.9631

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  36 in total

1.  Plasmids of Escherichia coli as cloning vectors.

Authors:  F Bolivar; K Backman
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  Aminoacyl-tRNA binding at the recognition site is the first step of the elongation cycle of protein synthesis.

Authors:  J A Lake
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

3.  Nature of Col E 1 plasmid replication in Escherichia coli in the presence of the chloramphenicol.

Authors:  D B Clewell
Journal:  J Bacteriol       Date:  1972-05       Impact factor: 3.490

4.  Comparison of the action of streptomycin and neomycin on the structure of the bacterial ribosome.

Authors:  J Noreau; L Grisé-Miron; L Brakier-Gingras
Journal:  Biochim Biophys Acta       Date:  1980-06-27

5.  Effect of Mg2+ concentration, polyamines, streptomycin, and mutations in ribosomal proteins on the accuracy of the two-step selection of aminoacyl-tRNAs in protein biosynthesis.

Authors:  R C Thompson; D B Dix; R B Gerson; A M Karim
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

6.  A system for shotgun DNA sequencing.

Authors:  J Messing; R Crea; P H Seeburg
Journal:  Nucleic Acids Res       Date:  1981-01-24       Impact factor: 16.971

7.  Binding of dihydrostreptomycin to Escherichia coli ribosomes: characteristics and equilibrium of the reaction.

Authors:  F N Chang; J G Flaks
Journal:  Antimicrob Agents Chemother       Date:  1972-10       Impact factor: 5.191

8.  The binding of non-cognate Tyr-tRNATyr to poly(uridylic acid)-programmed Escherichia coli ribosomes.

Authors:  S Campuzano; M J Cabañas; J Modolell
Journal:  Eur J Biochem       Date:  1979-10

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Paromomycin and dihydrostreptomycin binding to Escherichia coli ribosomes.

Authors:  D Lando; M A Cousin; T Ojasoo; J P Raymond
Journal:  Eur J Biochem       Date:  1976-07-15
View more
  44 in total

1.  Novel approach for improving the productivity of antibiotic-producing strains by inducing combined resistant mutations.

Authors:  H Hu; K Ochi
Journal:  Appl Environ Microbiol       Date:  2001-04       Impact factor: 4.792

2.  Single-base mutations at position 2661 of Escherichia coli 23S rRNA increase efficiency of translational proofreading.

Authors:  P Melançon; W E Tapprich; L Brakier-Gingras
Journal:  J Bacteriol       Date:  1992-12       Impact factor: 3.490

3.  A ribosomal ambiguity mutation in the 530 loop of E. coli 16S rRNA.

Authors:  M O'Connor; H U Göringer; A E Dahlberg
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

4.  Structural analysis of the 5' domain of the HeLa 18S ribosomal RNA by chemical and enzymatic probing.

Authors:  V Mandiyan; M Boublik
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

5.  Evidence for several higher order structural elements in ribosomal RNA.

Authors:  C R Woese; R R Gutell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

6.  Mutations in the 915 region of Escherichia coli 16S ribosomal RNA reduce the binding of streptomycin to the ribosome.

Authors:  D Leclerc; P Melançon; L Brakier-Gingras
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

7.  Mutations conferring aminoglycoside and spectinomycin resistance in Borrelia burgdorferi.

Authors:  Daniel Criswell; Virginia L Tobiason; J Stephen Lodmell; D Scott Samuels
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

8.  Inactivation of KsgA, a 16S rRNA methyltransferase, causes vigorous emergence of mutants with high-level kasugamycin resistance.

Authors:  Kozo Ochi; Ji-Yun Kim; Yukinori Tanaka; Guojun Wang; Kenta Masuda; Hideaki Nanamiya; Susumu Okamoto; Shinji Tokuyama; Yoshikazu Adachi; Fujio Kawamura
Journal:  Antimicrob Agents Chemother       Date:  2008-11-10       Impact factor: 5.191

9.  Dominant lethal mutations in a conserved loop in 16S rRNA.

Authors:  T Powers; H F Noller
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

10.  Streptomycin resistance in mycobacteria.

Authors:  N Honoré; S T Cole
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.